RT Journal Article
SR Electronic
T1 Increase in SARS-CoV-2 seroprevalence in healthy blood donors after the second wave of COVID-19 pandemic in South-Eastern Italy: evidence for asymptomatic young individuals as potential virus spreaders
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.12.21260358
DO 10.1101/2021.07.12.21260358
A1 Antonucci, Francescopaolo
A1 Fiore, Josè Ramòn
A1 De Feo, Lucia
A1 Granato, Tommaso
A1 Di Stefano, Mariantonietta
A1 Faleo, Giuseppina
A1 Farhan Mohamed, Ahmed Mohamed
A1 Margaglione, Maurizio
A1 Centra, Michele
A1 Santantonio, Teresa Antonia
YR 2021
UL http://medrxiv.org/content/early/2021/07/16/2021.07.12.21260358.abstract
AB Background Italy has been the first among western countries to experience SARS-CoV-2 spread during which the southern regions were also heavily affected by the pandemic. To understand and monitor properly the evolution of COVID-19 pandemic, population based seroprevalence studies are a valid tool for the infection rates and effective prevalence of the SARS-CoV-2.Aim In this prospective study, we assessed the changes in SARS-CoV-2 seroprevalence rates among non-vaccinated blood donors in South-Eastern Italy over May 2020 to March 2021.Methods 8,183 healthy blood donors referring to the Transfusion Center at the University Hospital “Riuniti” of Foggia (Italy) for blood donation in the period May 2020-March 2021 were tested for anti-SARS-CoV-2 antibodies by Ortho Clinical Diagnostics VITROS® 3600. None of the considered subjects had a diagnosed symptomatic COVID-19 infection.Results Overall, 516 resulted positive for anti-SARS-CoV-2 IgG antibodies (6.3%, 95% CI, 0.03-0.15%), 387 (4.7%) were male and 129 (1.7%) female. A statistically significant increase in the seropositive population was found from May 2020 to March 2021 (Fisher’s p<0.001). The difference of the seroprevalence was significant in terms of age but not sex (2-sided p<0.05 for age; 2-sided p>0.05 for sex) in both groups.Conclusion Our study shows a significant increase in the SARS-CoV-2 seroprevalence among blood donors and suggests a potential role of asymptomatic individuals in continuing the spread of the pandemic. These results may contribute to establishing containment measures and priorities in vaccine campaigns.Competing Interest StatementThe authors have declared no competing interest.Funding Statementno funds to declareAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ospedali Riuniti di Foggia Etical committeeAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yeson request